Back to top
more

Senseonics (SENS)

(Delayed Data from AMEX)

$0.46 USD

0.46
8,641,681

0.00 (1.03%)

Updated Sep 19, 2025 04:00 PM ET

After-Market: $0.45 -0.01 (-2.17%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value B Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 33% (81 out of 245)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?

by Zacks Equity Research

Sector ETF report for XHE

Zacks Equity Research

Select Medical (SEM) Plans 3rd Hospital in Central Pennsylvania

by Zacks Equity Research

Select Medical (SEM) joins forces with UPMC to open its third inpatient rehabilitation hospital in Central Pennsylvania to better address the region's post-acute care needs.

Zacks Equity Research

Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for XHE

Zacks Equity Research

Encompass Health (EHC) Plans Hospital to Aid Florida Footprint

by Zacks Equity Research

Encompass Health (EHC) unveils plans to fortify its U.S. presence via building a 50-bed inpatient rehabilitation hospital in The Villages, Florida.

Zacks Equity Research

Cigna's (CI) Arm Adds Five Digital Health Apps to Its Platform

by Zacks Equity Research

Cigna's (CI) unit bolsters its clinical platform Digital Health Formulary by including five on-line solutions, aiming to relieve people from chronic medical conditions.

Zacks Equity Research

Humana (HUM) Brings Home Health Unit of KAH Under CenterWell

by Zacks Equity Research

Humana (HUM) wraps up rebranding KAH's home health operations to the CenterWell brand. This leads to the clubbing of HUM's three payer-agnostic care services into a common suite.

Zacks Equity Research

Senseonics Holdings (SENS) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Senseonics (SENS) delivered earnings and revenue surprises of 25% and 12.44%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Talkspace, Inc. (TALK) Reports Q2 Loss, Misses Revenue Estimates

by Zacks Equity Research

Talkspace, Inc. (TALK) delivered earnings and revenue surprises of -15.38% and 4.23%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Enovis (ENOV) Q2 Earnings Beat Estimates

by Zacks Equity Research

Enovis (ENOV) delivered earnings and revenue surprises of 20.41% and 1.39%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Syneos Health (SYNH) Beats Q2 Earnings Estimates

by Zacks Equity Research

Syneos Health (SYNH) delivered earnings and revenue surprises of 4.17% and 1.76%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Senseonics Holdings (SENS) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Senseonics (SENS) delivered earnings and revenue surprises of 0% and 16.15%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Syneos Health (SYNH) Q1 Earnings and Revenues Top Estimates

by Zacks Equity Research

Syneos Health (SYNH) delivered earnings and revenue surprises of 5.21% and 0.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Senseonics Holdings (SENS) Beats Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Senseonics (SENS) delivered earnings and revenue surprises of 133.33% and 0.20%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

AllScripts Healthcare (MDRX) Q4 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

AllScripts (MDRX) delivered earnings and revenue surprises of 154.84% and 0.08%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Fullgent Genetics (FLGT) Q4 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Fullgent Genetics (FLGT) delivered earnings and revenue surprises of 25.56% and 31.01%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Do Options Traders Know Something About Senseonics (SENS) Stock We Don't?

by Zacks Equity Research

Investors need to pay close attention to for Senseonics (SENS) stock based on the movements in the options market lately.

Zacks Equity Research

Are Options Traders Betting on a Big Move in Senseonics (SENS) Stock?

by Zacks Equity Research

Investors need to pay close attention to Senseonics (SENS) stock based on the movements in the options market lately.

Zacks Equity Research

Senseonics Holdings (SENS) Reports Q3 Loss, Misses Revenue Estimates

by Zacks Equity Research

Senseonics (SENS) delivered earnings and revenue surprises of 57.14% and -4.02%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Senseonics Holdings (SENS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

by Zacks Equity Research

Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Implied Volatility Surging for Senseonics (SENS) Stock Options

by Zacks Equity Research

Investors need to pay close attention to Senseonics (SENS) stock based on the movements in the options market lately.

Zacks Equity Research

Implied Volatility Surging for Senseonics Holdings (SENS) Stock Options

by Zacks Equity Research

Investors need to pay close attention to Senseonics Holdings (SENS) stock based on the movements in the options market lately.

Zacks Equity Research

Senseonics Holdings (SENS) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Senseonics (SENS) delivered earnings and revenue surprises of -150.00% and 9.74%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Senseonics Holdings (SENS) Flat As Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, Senseonics Holdings (SENS) closed at $3.03, marking no change from the previous day.

Zacks Equity Research

What's in Store for Senseonics Holdings' (SENS) Q2 Earnings?

by Zacks Equity Research

Senseonics Holdings' (SENS) second-quarter results are likely to gain from higher sales outside the United States.

Zacks Equity Research

Senseonics Holdings (SENS) Flat As Market Sinks: What You Should Know

by Zacks Equity Research

In the latest trading session, Senseonics Holdings (SENS) closed at $3.05, marking no change from the previous day.